Ashley Chamberland
Pediatrics · Lampasas, TXNPI 1023243763
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 26.0% of the total. Reporting peaked in 2023 at $646 and has fallen 71.8% since, to $182 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$739
- Corium, LLC$278
- Novo Nordisk$259
- Supernus Pharmaceuticals, Inc.$185
- Dexcom, Inc.$171
- Merck$134
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,81699%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 51 | $739 |
| Corium, LLC | 11 | $278 |
| Novo Nordisk | 14 | $259 |
| Supernus Pharmaceuticals, Inc. | 11 | $185 |
| Dexcom, Inc. | 11 | $171 |
| Merck | 9 | $134 |
| Tris Pharma Inc | 7 | $108 |
| Amgen | 7 | $98 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Pfizer | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $72 |
| AstraZeneca | 5 | $65 |
| Abbott | 3 | $62 |
| Cranial Technologies, Inc | 4 | $62 |
| Amarin Pharma, Inc. | 3 | $52 |
| Idorsia Pharmaceuticals US Inc | 3 | $51 |
| GSK | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $39 |
| Corcept Therapeutics | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Boehringer Ingelheim | 1 | $24 |
| Averitas Pharma Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Biogen | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
| Novartis | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,845 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Lampasas
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
- Ralph DeberardinisDallas$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.